Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Gynecologie, Obstetrique, Fertilite & Senologie
|
November 15, 2017
[Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)]
D Querleu, E Darai, F Lecuru, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2014
The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors
P A Cassier, A Floquet, N Penel, et al.
Anticancer Research
|
March 9, 2012
Combined oral topotecan plus carboplatin in relapsed or advanced cervical cancer: a GINECO phase I-II trial
J E Kurtz, G Freyer, F Joly, et al.
British Journal of Cancer
|
August 14, 2003
DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer
G MacGrogan, P Rudolph, I de Mascarel Id, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2014
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia
C Even, P Pautier, P Duvillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2011
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study
J E Kurtz, M C Kaminsky, A Floquet, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 18, 2019
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group
Marie Meurer, A Floquet, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2017
Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial
A Bamias, E Gibbs, C Khoon Lee, et al.
Gynecologic Oncology
|
October 15, 2021
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study
F Gernier, A Gompel, C Rousset-Jablonski, et al.
ESMO Open
|
July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
P Pautier, A Floquet, C Chevreau, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Gynecologie, Obstetrique, Fertilite & Senologie
|
November 15, 2017
[Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)]
D Querleu, E Darai, F Lecuru, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2014
The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors
P A Cassier, A Floquet, N Penel, et al.
Anticancer Research
|
March 9, 2012
Combined oral topotecan plus carboplatin in relapsed or advanced cervical cancer: a GINECO phase I-II trial
J E Kurtz, G Freyer, F Joly, et al.
British Journal of Cancer
|
August 14, 2003
DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer
G MacGrogan, P Rudolph, I de Mascarel Id, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2014
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia
C Even, P Pautier, P Duvillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2011
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study
J E Kurtz, M C Kaminsky, A Floquet, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 18, 2019
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group
Marie Meurer, A Floquet, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2017
Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial
A Bamias, E Gibbs, C Khoon Lee, et al.
Gynecologic Oncology
|
October 15, 2021
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study
F Gernier, A Gompel, C Rousset-Jablonski, et al.
ESMO Open
|
July 29, 2021
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
P Pautier, A Floquet, C Chevreau, et al.
Page
of 5